An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 21, Issue 9, 2006, Pages 2406-2416

  Han, Sang Youb ^a   Jee, Yi Hwa ^b   Han, Kum Hyun ^b   Kang, Young Sun ^b   Kim, Hyoung Kyu ^b   Han, Jee Young ^c   Kim, Young Sik ^b   Cha, Dae Ryong ^b  

^a Inje University   (South Korea)

^b Korea University   (South Korea)

^c Inha University   (South Korea)

Author keywords

Angiotensin II; Diabetic nephropathy; High glucose; Matrix metalloproteinase 2; Proximal tubule cell; Tissue inhibitor of matrix metalloproteinase 2

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; COLLAGEN; GELATINASE A; GLUCOSE; PROTEIN; STREPTOZOCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; COLLAGEN TYPE 4; MESSENGER RNA; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; MALE; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR INTRINSIC ACTIVITY; RNA EXTRACTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; GENETICS; IN VITRO STUDY; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CELL LINE; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; GENE EXPRESSION; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES, PROXIMAL; MALE; MATRIX METALLOPROTEINASE 2; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33750121618     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl238     Document Type: Article

References (21)

1. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 2003; 253: 269-285
2. Prete DD, Anglani F, Forino M et al. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia 1997; 40: 1449-1454
3. Wu K, Setty S, Mauer SM et al. Altered kidney matrix gene expression in early stages of experimental diabetes. Acta Anat 1997; 158: 155-165
4. Schaefer L, Han X, August C, Matzkies F, Lorenz T, Schaefer RM. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats. Diabetologia 1997; 40: 1035-1043
5. McLennan SV, Fisher E, Martell SY et al. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: Possible role in diabetic nephropathy. Kidney Int 2000; 77 [Suppl]: S81-S87
6. Ziyadeh FN, Goldfarb S. The renal tubulointerstitium in diabetes mellitus. Kidney Int 1991; 39: 464-475
7. Bader R, Bader H, Grund KE, Markensen S, Christ H, Bohle A. Structure and function of the kidney in diabetic glomerulosclerosis: Correlations between morphologic and functional parameters. Pathol Res Prac 1980; 167: 204-216
8. Strutz F, Muller GA. Interstitial pathomechanisms underlying progressive tubulointerstitial damage. Kidney Blood Press Res 1999; 22: 71-80
9. van Kooten C, Langers AM, Bruijn JA, Daha MR. Role of tubular cells in progressive renal disease. Kidney Blood Press Res 1999; 22: 53-61
10. Okada H, Inoue T, Suzuki H, Strutz F, Neilson EG. Epithelialmesenchymal transformation of renal tubular epithelial cells in vitro and in vivo. Nephrol Dial Transplant 2000; 15: 44-46
11. Karamessinis PM, Tzinia AK, Kitsiou PV et al. Proximal tubular epithelial cell integrins response to high glucose by altered cell-matrix interactions and differentially regulate matrixin expression. Lab Invest 2002; 82: 1081-1093
12. Arenas IA, Xu Y, Lopez-Jaramillo L, Davidge ST. Angiotensin II induced MMP-2 release from endothelial cells is mediated by TNF-α. Am J Physiol Cell Physiol 2004; 286: C779-C784
13. Pasterkamp G, Schoneveld AH, Hijnen DJ et al. Artherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteinase 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000; 150: 245-253
14. Lelongt B, Legallicier B, Piedagnel R, Ronco PM. Do matrix metalloproteinases MMP-2 and MMP-9 (gelatinases) play a role in renal development, physiology and glomerular diseases? Curr Opin Nephrol Hypert 2001; 10: 7-12
15. Phillips AO, Steadman R, Morrisey K, Martin J, Eynstone L, Williams JD. Exposure of human proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 1997; 52: 973-984
16. McLennan SV, Kelly DJ, Cox AJ et al. Decreased matrix degradation in diabetic nephropathy: Effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45: 268-275
17. Min LJ, Cui TX, Yahata Y et al. Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes. Endocrinology 2004; 145: 253-260
18. Kitsiou PV, Tzinia AK, Stetler-Stevenson WG et al. Glucoseinduced changes in integrins and matrix related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol 2002; 284: F671-F679
19. McLennan SV, Martell SK, Yue DK. Effects of mesangium glycation on matrix metalloproteinase activities: Possible role in diabetic nephropathy. Diabetes 2002; 51: 2612-2618
20. Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Exp Nephrol 2001; 9: 249-257
21. Baricos WH, Cortez SL, Deboisblanc M, Xin S. Transforming growth factor is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells. J Am Soc Nephrol 1999; 10: 790-795